Cranberry

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Cranberry
Accession Number
DB10631
Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Allergenics
Allergen Extract
Description

Cranberry allergenic extract is used in allergenic testing.

Synonyms
Not Available
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
CranberrySolution0.025 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
CranberryInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
CranberryInjection, solution1 g/20mLPercutaneous; SubcutaneousAllergy Laboratories, Inc.1972-08-29Not applicableUs
CranberryInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
CranberryInjection, solution0.05 g/1mLIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-03-23Not applicableUs
CranberryInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
CranberryInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Categories
UNII
0MVO31Q3QS
CAS number
Not Available

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910771
Wikipedia
Cranberry

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1CompletedSupportive CareUrinary Bladder, Overactive1
2CompletedPreventionUrinary Tract Infections (UTIs)1
3CompletedPreventionBladder Dysfunction / Disseminated Sclerosis / Urinary Tract Infections (UTIs)1
4WithdrawnPreventionUrinary Tract Infections (UTIs)1
Not AvailableRecruitingPreventionPelvic Organ Prolapse (POP) / Urinary Incontinence (UI) / Urinary Tract Infections (UTIs)1
Not AvailableRecruitingPreventionUrinary Tract Infections, Recurrent1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionPercutaneous; Subcutaneous1 g/20mL
SolutionIntradermal; Percutaneous; Subcutaneous0.025 g/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:04 / Updated on June 04, 2019 07:14